Literature DB >> 15254596

Regulation of pulmonary fibrosis by chemokine receptor CXCR3.

Dianhua Jiang1, Jiurong Liang, Jennifer Hodge, Bao Lu, Zhou Zhu, Shuang Yu, Juan Fan, Yunfei Gao, Zhinan Yin, Robert Homer, Craig Gerard, Paul W Noble.   

Abstract

CXC chemokine receptor 3 (CXCR3) is the receptor for the IFN-gamma-inducible C-X-C chemokines MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11. CXCR3 is expressed on activated immune cells and proliferating endothelial cells. The role of CXCR3 in fibroproliferation has not been investigated. We examined the role of CXCR3 in pulmonary injury and repair in vivo. CXCR3-deficient mice demonstrated increased mortality with progressive interstitial fibrosis relative to WT mice. Increased fibrosis occurred without increased inflammatory cell recruitment. CXCR3 deficiency resulted in both a reduced early burst of IFN-gamma production and decreased expression of CXCL10 after lung injury. We identified a relative deficiency in lung NK cells in the unchallenged CXCR3-deficient lung and demonstrated production of IFN-gamma by WT lung NK cells in vivo following lung injury. The fibrotic phenotype in the CXCR3-deficient mice was significantly reversed following administration of exogenous IFN-gamma or restoration of endogenous IFN-gamma production by adoptive transfer of WT lymph node and spleen cells. Finally, pretreatment of WT mice with IFN-gamma-neutralizing Ab's enhanced fibrosis following lung injury. These data demonstrate a nonredundant role for CXCR3 in limiting tissue fibroproliferation and suggest that this effect may be mediated, in part, by the innate production of IFN-gamma following lung injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254596      PMCID: PMC449741          DOI: 10.1172/JCI16861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.

Authors:  Simona Frigerio; Tobias Junt; Bao Lu; Craig Gerard; Urs Zumsteg; Georg A Holländer; Luca Piali
Journal:  Nat Med       Date:  2002-11-04       Impact factor: 53.440

2.  Systemic chemokine and chemokine receptor responses are divergent in allergic versus non-allergic humans.

Authors:  J Darren Campbell; Monique J Stinson; F Estelle R Simons; Kent T HayGlass
Journal:  Int Immunol       Date:  2002-11       Impact factor: 4.823

3.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Authors:  M Loetscher; B Gerber; P Loetscher; S A Jones; L Piali; I Clark-Lewis; M Baggiolini; B Moser
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells.

Authors:  Elisabetta Ferrero; Priscilla Biswas; Katuscia Vettoretto; Marina Ferrarini; Mariagrazia Uguccioni; Luca Piali; Biagio Eugenio Leone; Bernhard Moser; Claudio Rugarli; Ruggero Pardi
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

5.  Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.

Authors:  Ming Jiankuo; Wang Xingbing; Huang Baojun; Wu Xiongwin; Li Zhuoya; Xiong Ping; Xu Yong; Liu Anting; Hu Chunsong; Gong Feili; Tan Jinquan
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

6.  The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues.

Authors:  Hiroaki Kabashima; Masahiro Yoneda; Kengo Nagata; Takao Hirofuji; Katsumasa Maeda
Journal:  Cytokine       Date:  2002-10-21       Impact factor: 3.861

7.  IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation.

Authors:  Anne Krug; Ravindra Uppaluri; Fabio Facchetti; Brigitte G Dorner; Kathleen C F Sheehan; Robert D Schreiber; Marina Cella; Marco Colonna
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.

Authors:  Ping Gao; Xu-Yu Zhou; Yumi Yashiro-Ohtani; Yi-Fu Yang; Naotoshi Sugimoto; Shiro Ono; Tsuyoshi Nakanishi; Satoshi Obika; Takeshi Imanishi; Takeshi Egawa; Takashi Nagasawa; Hiromi Fujiwara; Toshiyuki Hamaoka
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

9.  Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression.

Authors:  G Gurujeyalakshmi; S N Giri
Journal:  Exp Lung Res       Date:  1995 Sep-Oct       Impact factor: 2.459

10.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.

Authors:  A D Luster; P Leder
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  119 in total

1.  Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.

Authors:  Dianhua Jiang; Jiurong Liang; Rishu Guo; Ting Xie; Francine L Kelly; Tereza Martinu; Ting Yang; Alysia K Lovgren; Jessica Chia; Ningshan Liu; Yoosun Jung; Scott M Palmer; Paul W Noble
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

Review 2.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

3.  Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis.

Authors:  Robert M Strieter; Michael P Keane
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

4.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

5.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

6.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

Review 7.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Authors:  Arthur C Huen; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

8.  Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay.

Authors:  L A Jopling; G F Watt; S Fisher; H Birch; S Coggon; M I Christie
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

9.  Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection.

Authors:  Ting Jia; Natalya V Serbina; Katharina Brandl; Maggie X Zhong; Ingrid M Leiner; Israel F Charo; Eric G Pamer
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

10.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.